Jessica E Malberg - Publications

Affiliations: 
 
Area:
Depression, antidepressant, neurogenesis

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2009 Sukoff Rizzo SJ, Pulicicchio C, Malberg JE, Andree TH, Stack GP, Hughes ZA, Schechter LE, Rosenzweig-Lipson S. 5-HT(1A) receptor antagonism reverses and prevents fluoxetine-induced sexual dysfunction in rats. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 1045-53. PMID 19435548 DOI: 10.1017/S1461145709000406  0.96
2009 Cho SJ, Jensen NH, Kurome T, Kadari S, Manzano ML, Malberg JE, Caldarone B, Roth BL, Kozikowski AP. Selective 5-hydroxytryptamine 2C receptor agonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action. Journal of Medicinal Chemistry. 52: 1885-902. PMID 19284718 DOI: 10.1021/jm801354e  0.96
2008 Hoshaw BA, Hill TI, Crowley JJ, Malberg JE, Khawaja X, Rosenzweig-Lipson S, Schechter LE, Lucki I. Antidepressant-like behavioral effects of IGF-I produced by enhanced serotonin transmission. European Journal of Pharmacology. 594: 109-16. PMID 18675266 DOI: 10.1016/j.ejphar.2008.07.023  0.96
2008 Malberg JE, Monteggia LM. VGF, a new player in antidepressant action? Science Signaling. 1: pe19. PMID 18460680 DOI: 10.1126/stke.118pe19  0.96
2008 Balu DT, Hoshaw BA, Malberg JE, Rosenzweig-Lipson S, Schechter LE, Lucki I. Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments. Brain Research. 1211: 37-43. PMID 18433734 DOI: 10.1016/j.brainres.2008.03.023  0.96
2008 Leonard SK, Dwyer JM, Sukoff Rizzo SJ, Platt B, Logue SF, Neal SJ, Malberg JE, Beyer CE, Schechter LE, Rosenzweig-Lipson S, Ring RH. Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology. 197: 601-11. PMID 18311561 DOI: 10.1007/s00213-008-1080-4  0.96
2007 Gur TL, Conti AC, Holden J, Bechtholt AJ, Hill TE, Lucki I, Malberg JE, Blendy JA. cAMP response element-binding protein deficiency allows for increased neurogenesis and a rapid onset of antidepressant response. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 7860-8. PMID 17634380 DOI: 10.1523/JNEUROSCI.2051-07.2007  0.96
2007 Malberg JE, Platt B, Rizzo SJ, Ring RH, Lucki I, Schechter LE, Rosenzweig-Lipson S. Increasing the levels of insulin-like growth factor-I by an IGF binding protein inhibitor produces anxiolytic and antidepressant-like effects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 2360-8. PMID 17342171 DOI: 10.1038/sj.npp.1301358  0.96
2007 Kwak SP, Malberg JE, Howland DS, Cheng KY, Su J, She Y, Fennell M, Ghavami A. Ablation of central nervous system progenitor cells in transgenic rats using bacterial nitroreductase system. Journal of Neuroscience Research. 85: 1183-93. PMID 17304579 DOI: 10.1002/jnr.21223  0.96
2007 Rosenzweig-Lipson S, Sabb A, Stack G, Mitchell P, Lucki I, Malberg JE, Grauer S, Brennan J, Cryan JF, Sukoff Rizzo SJ, Dunlop J, Barrett JE, Marquis KL. Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents. Psychopharmacology. 192: 159-70. PMID 17297636 DOI: 10.1007/s00213-007-0710-6  0.96
2007 Rosenzweig-Lipson S, Beyer CE, Hughes ZA, Khawaja X, Rajarao SJ, Malberg JE, Rahman Z, Ring RH, Schechter LE. Differentiating antidepressants of the future: efficacy and safety. Pharmacology & Therapeutics. 113: 134-53. PMID 17010443 DOI: 10.1016/j.pharmthera.2006.07.002  0.96
2006 Ring RH, Malberg JE, Potestio L, Ping J, Boikess S, Luo B, Schechter LE, Rizzo S, Rahman Z, Rosenzweig-Lipson S. Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology. 185: 218-25. PMID 16418825 DOI: 10.1007/s00213-005-0293-z  0.96
2005 Schechter LE, Ring RH, Beyer CE, Hughes ZA, Khawaja X, Malberg JE, Rosenzweig-Lipson S. Innovative approaches for the development of antidepressant drugs: current and future strategies. Neurorx : the Journal of the American Society For Experimental Neurotherapeutics. 2: 590-611. PMID 16489368 DOI: 10.1602/neurorx.2.4.590  0.52
2005 Malberg JE, Blendy JA. Antidepressant action: to the nucleus and beyond. Trends in Pharmacological Sciences. 26: 631-8. PMID 16246434 DOI: 10.1016/j.tips.2005.10.005  0.96
2005 Hoshaw BA, Malberg JE, Lucki I. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Research. 1037: 204-8. PMID 15777771 DOI: 10.1016/j.brainres.2005.01.007  0.96
2005 Malberg JE, Schechter LE. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Current Pharmaceutical Design. 11: 145-55. PMID 15638755  0.52
2003 Malberg JE, Duman RS. Cell proliferation in adult hippocampus is decreased by inescapable stress: reversal by fluoxetine treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 1562-71. PMID 12838272 DOI: 10.1038/sj.npp.1300234  0.96
2002 Nakagawa S, Kim JE, Lee R, Malberg JE, Chen J, Steffen C, Zhang YJ, Nestler EJ, Duman RS. Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 22: 3673-82. PMID 11978843  0.96
Show low-probability matches.